High mobility group B1 levels in sepsis and disseminated intravascular coagulation

Acta Biochimica Polonica

Volumn 59, Issue 4, 2012, Pages 561-566

  Eskici, Zeynep M ^a   Açikgöz, Şerefden ^a   Pişkin, Nihal ^a   Mungan, Görkem ^a   Can, Murat ^a   Güven, Berrak ^a   Köktürk, Fürüzan ^a  

^a Faculty of Arts and Sciences   (Turkey)

Author keywords

Disseminated intravascular coagulation; HMGB1; Sepsis

Indexed keywords

EID: 84873738228     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2012_2092     Document Type: Article

References (24)

1. Bochud PY, Calandra T (2003) Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326: 262-266.
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) ACCP/SCCM Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655.
3. Cinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37: 291-304.
4. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420:885-891.
5. Flohr AM, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B et al (2001) Variation of HMGB1 expression in breast cancer. Anticancer Res 21: 3881-3885.
6. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A. et al (1992) Septic shock, multiple organ failure and disseminated intravascular coagulation compared patterns of antithrombin III, protein C and protein S deficiencies. Chest 101: 816-823.
7. Gaini S, Koldkjaer OG, Møller HJ, Pedersen C, Pedersen SS (2007) A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe communityacquired infections and bacteraemia: a prospective study. Crit Care 11: R76.
8. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B et al (2007) High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33: 1347-1353.
9. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y et al (2005) Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 94: 975-979.
10. Karlsson S, Pettilä V, Tenhunen J, Laru-Sompa R, Hynninen M, Ruokonen E (2008) HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 34: 1046-1053.
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med 29: 530-538.
12. Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145: 24-33.
13. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
14. Mujun Y, Nardella A, BS, MT(ASCP), SH; Pechet L (2000) Screening tests of disseminated intravascular coagulation: Guidelines for rapid and specific laboratory diagnosis. Crit Care Med 28: 1777-1780.
15. Peters K, Unger RE, Brunner J, Kirkpatrick CJ (2003) Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 60: 49-57.
16. Poser I, Golob M, Buettner R, Bosserhoff AK (2003) Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 23: 2991-2998.
17. Shimaoka M, Park EJ. (2008) Advances in understanding sepsis. Eur J Anaesthesiol Suppl 42: 146-53.
18. Sundén-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ et al (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33: 564-573.
19. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 86: 1327-1330.
20. Ulloa L, Tracey KJ (2005) The 'cytokine profile': a code for sepsis. Trends Mol Med 11: 56-63.
21. Van Zoelen MA, Laterre PF, Van Veen SQ, Van Till JW, Wittebole X, Bresser P et al (2007) Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 35: 2799-2804.
22. Völp K, Brezniceanu ML, Bösser S, Brabletz T, Kirchner T, Göttel D et al (2006) Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55: 234-242.
23. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
24. Zeerleder S, Hack CE, Wuillemin WA (2005) Disseminated intravascular coagulation in sepsis. Chest 128: 2864-2875.